Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Baiyun Yao"'
Autor:
Henry A. Nasrallah, Peter J. Weiden, David P. Walling, Yangchun Du, Baiyun Yao, Sergey Yagoda, Amy Claxton
Publikováno v:
BMC Psychiatry, Vol 21, Iss 1, Pp 1-13 (2021)
Abstract Background A randomized, controlled, phase 3b study (ALPINE) evaluated efficacy and safety of a 2-month formulation of aripiprazole lauroxil (AL) using a 1-day initiation regimen in patients hospitalized for an acute exacerbation of schizoph
Externí odkaz:
https://doaj.org/article/eadc67c7e7c04be7af8d394b3a87cbf9
Autor:
Yangchun Du, Henry A. Nasrallah, Baiyun Yao, Peter J. Weiden, David P. Walling, Amy Claxton, Sergey Yagoda
Publikováno v:
BMC Psychiatry
BMC Psychiatry, Vol 21, Iss 1, Pp 1-13 (2021)
BMC Psychiatry, Vol 21, Iss 1, Pp 1-13 (2021)
Background A randomized, controlled, phase 3b study (ALPINE) evaluated efficacy and safety of a 2-month formulation of aripiprazole lauroxil (AL) using a 1-day initiation regimen in patients hospitalized for an acute exacerbation of schizophrenia. Pa
Autor:
Ethan Cash, Jelena Kunovac, Sergey Yagoda, Yangchun Du, Amy Claxton, Peter J. Weiden, Ilda Bidollari, David P. Walling, Baiyun Yao, Elizabeth Keane
Publikováno v:
The Journal of clinical psychiatry. 81(3)
OBJECTIVE Evaluate efficacy and safety of a 2-month formulation of aripiprazole lauroxil (AL) with 1-day initiation during hospitalization for acute exacerbation of schizophrenia followed by transition to outpatient care. METHODS The phase 3b double-
Autor:
Yangchun Du, Henry Nasrallah, Baiyun Yao, Amy Claxton, Sergey Yagoda, Peter J. Weiden, David P. Walling
Publikováno v:
CNS Spectrums. 26:171-172
ObjectiveThe randomized, controlled, phase 3b ALPINE study evaluated efficacy and safety of a 2-month formulation of aripiprazole lauroxil (AL) initiated with a 1-day regimen during hospitalization for an acute exacerbation of schizophrenia; paliperi
Publikováno v:
Clinical Drug Investigation
Background and Objective Olanzapine is an atypical antipsychotic indicated for the treatment of schizophrenia and, either as monotherapy or as an adjunct to lithium or valproate, for bipolar I disorder. Multiple daily doses of olanzapine do not affec
Publikováno v:
Schizophrenia Bulletin
Background Patients with schizophrenia are known to experience many problems across the 24-hour sleep-wake cycle (SWC), including lower daytime physical activity levels, as well as a range of problems in nighttime sleep quality. However, self-report
Autor:
Weiden, Peter J., Claxton, Amy, Kunovac, Jelena, Walling, David P., Yangchun Du, Baiyun Yao, Yagoda, Sergey, Bidollari, Ilda, Keane, Elizabeth, Cash, Ethan
Publikováno v:
Journal of Clinical Psychiatry; May/Jun2020, Vol. 81 Issue 3, p27-35, 9p
Publikováno v:
Schizophrenia Bulletin; 2020 Supplement, Vol. 46, pS175-S175, 1/2p
Autor:
Xiaofei Tian
Winner of a 2006 Choice Magazine Outstanding Academic Title AwardAs medieval Chinese manuscripts were copied and recopied through the centuries, both mistakes and deliberate editorial changes were introduced, thereby affecting readers'impressions of